These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22275380)

  • 1. HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.
    Zhang H; Li H; Xi HS; Li S
    Blood; 2012 Mar; 119(11):2595-607. PubMed ID: 22275380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.
    Zhang B; Li M; McDonald T; Holyoake TL; Moon RT; Campana D; Shultz L; Bhatia R
    Blood; 2013 Mar; 121(10):1824-38. PubMed ID: 23299311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YBX1 regulates the survival of chronic myeloid leukemia stem cells by modulating m
    Chai J; Wang Q; Qiu Q; Han G; Chen Y; Li W; Zhang H
    Cell Oncol (Dordr); 2023 Apr; 46(2):451-464. PubMed ID: 36512307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
    Wang Z; Chen CC; Chen W
    Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia.
    Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G
    Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.
    Höpner SS; Raykova A; Radpour R; Amrein MA; Koller D; Baerlocher GM; Riether C; Ochsenbein AF
    Nat Commun; 2021 Feb; 12(1):1065. PubMed ID: 33594067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.
    Chen Y; Sullivan C; Peng C; Shan Y; Hu Y; Li D; Li S
    Blood; 2011 Jul; 118(2):390-400. PubMed ID: 21596859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL-initiating cells.
    Sengupta A; Ficker AM; Dunn SK; Madhu M; Cancelas JA
    Blood; 2012 Jan; 119(2):494-502. PubMed ID: 22101899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.
    Ng KP; Manjeri A; Lee KL; Huang W; Tan SY; Chuah CT; Poellinger L; Ong ST
    Blood; 2014 May; 123(21):3316-26. PubMed ID: 24705490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
    Hansen N; Ågerstam H; Wahlestedt M; Landberg N; Askmyr M; Ehinger M; Rissler M; Lilljebjörn H; Johnels P; Ishiko J; Melo JV; Alexander WS; Bryder D; Järås M; Fioretos T
    Leukemia; 2013 Jan; 27(1):130-5. PubMed ID: 22824785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.
    Cheloni G; Tanturli M; Tusa I; Ho DeSouza N; Shan Y; Gozzini A; Mazurier F; Rovida E; Li S; Dello Sbarba P
    Blood; 2017 Aug; 130(5):655-665. PubMed ID: 28576876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion.
    Hayashi Y; Hirai H; Kamio N; Yao H; Yoshioka S; Miura Y; Ashihara E; Fujiyama Y; Tenen DG; Maekawa T
    Leukemia; 2013 Mar; 27(3):619-28. PubMed ID: 22948537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.
    Schürch C; Riether C; Matter MS; Tzankov A; Ochsenbein AF
    J Clin Invest; 2012 Feb; 122(2):624-38. PubMed ID: 22232214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
    Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
    J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell resolution reveals RalA GTPase expanding hematopoietic stem cells and facilitating of BCR-ABL1-driven leukemogenesis in a CRISPR/Cas9 gene editing mouse model.
    Yin Z; Su R; Ge L; Wang X; Yang J; Huang G; Li C; Liu Y; Zhang K; Deng L; Fei J
    Int J Biol Sci; 2023; 19(4):1211-1227. PubMed ID: 36923939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.
    Chen Y; Hu Y; Zhang H; Peng C; Li S
    Nat Genet; 2009 Jul; 41(7):783-92. PubMed ID: 19503090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
    Hu Y; Chen Y; Douglas L; Li S
    Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia.
    Zhang H; Li H; Ho N; Li D; Li S
    Mol Cell Biol; 2012 May; 32(10):1776-87. PubMed ID: 22431519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.